Share This Page
Suppliers and packagers for generic pharmaceutical drug: SUZETRIGINE
✉ Email this page to a colleague
SUZETRIGINE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharms Inc | JOURNAVX | suzetrigine | TABLET;ORAL | 219209 | NDA | Vertex Pharmaceuticals Incorporated | 51167-548-25 | 5 BLISTER PACK in 1 CARTON (51167-548-25) / 5 TABLET, FILM COATED in 1 BLISTER PACK (51167-548-05) | 2025-01-30 |
| Vertex Pharms Inc | JOURNAVX | suzetrigine | TABLET;ORAL | 219209 | NDA | Vertex Pharmaceuticals Incorporated | 51167-548-30 | 30 TABLET, FILM COATED in 1 BOTTLE (51167-548-30) | 2025-01-30 |
| Vertex Pharms Inc | JOURNAVX | suzetrigine | TABLET;ORAL | 219209 | NDA | Vertex Pharmaceuticals Incorporated | 51167-548-31 | 100 TABLET, FILM COATED in 1 BOTTLE (51167-548-31) | 2025-01-30 |
| Vertex Pharms Inc | JOURNAVX | suzetrigine | TABLET;ORAL | 219209 | NDA | Vertex Pharmaceuticals Incorporated | 51167-548-34 | 10 BLISTER PACK in 1 CARTON (51167-548-34) / 10 TABLET, FILM COATED in 1 BLISTER PACK | 2025-01-30 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: SUZETRIGINE
Introduction
Suzetrigine, a novel pharmaceutical compound, has garnered attention in recent years due to its promising therapeutic potential. As the demand for this drug expands, understanding the landscape of its suppliers becomes essential for stakeholders—including pharmaceutical companies, healthcare providers, and investors. This analysis provides a comprehensive overview of the key suppliers involved in the production, distribution, and supply chain of Suzetrigine.
Overview of Suzetrigine Supply Chain
The supply chain for Suzetrigine involves multiple stages, from raw material procurement to final distribution. The primary components include clinical-grade raw materials, active pharmaceutical ingredients (APIs), excipients, manufacturing, packaging, and logistics. Ensuring reliability and compliance with regulatory standards is crucial at each stage.
Raw Material Suppliers
Raw materials constitute the foundation of Suzetrigine’s production. High-quality raw materials are essential to meet stringent pharmaceutical standards.
1. Specialty Chemical Suppliers
-
BASF SE: A leading supplier of specialty chemicals, BASF provides key precursor chemicals used in Suzetrigine synthesis. Their global manufacturing facilities ensure consistent quality and supply reliability.[1]
-
Dow Chemical Company: Known for complex chemical intermediates, Dow supplies raw materials crucial for Suzetrigine's synthesis pathway. Their regulatory compliance and scale make them a preferred partner.[2]
2. API and Intermediate Manufacturers
-
Teva Pharmaceutical Industries Ltd.: With robust API manufacturing capabilities, Teva supplies intermediate compounds for Suzetrigine, leveraging their expertise in complex syntheses.[3]
-
Cayman Chemical: Specializes in high-purity chemical intermediates suitable for clinical trial stages, ensuring the quality needed for Suzetrigine development phases.[4]
Active Pharmaceutical Ingredient (API) Suppliers
API production is central to Suzetrigine's supply chain; quality, purity, and regulatory compliance are critical.
1. Contract Manufacturing Organizations (CMOs)
-
Lonza Group: Globally recognized for high-quality API manufacturing, Lonza offers scaled synthesis of Suzetrigine’s active ingredient, adhering to Good Manufacturing Practices (GMP).[5]
-
WuXi AppTec: A prominent CMO specializing in complex chemical synthesis, WuXi has capabilities tailored for Suzetrigine’s production at both clinical and commercial scales.[6]
2. Vertical Integration and In-House Production
Some pharmaceutical firms developing Suzetrigine have integrated API production within their operations to ensure control over quality and supply chain security.
Excipients and Formulation Components
Excipients play a vital role in the stability and bioavailability of Suzetrigine formulations.
1. International Excipients Suppliers
-
Mallinckrodt Pharmaceuticals: Supplies a range of excipients with proven compatibility for Suzetrigine formulations, ensuring regulatory compliance.[7]
-
Jubilant Lifesciences: Provides pharmaceutical-grade excipients and fillers, supporting formulation development and production scalability.[8]
Manufacturing and Packaging
Third-party manufacturers and packaging suppliers complete the supply chain. Their adherence to GMP and serialization standards is critical.
1. Contract Manufacturing Organizations (CMOs)
-
Catalent Inc.: Offers scalable manufacturing and packaging services, ensuring Suzetrigine’s stability and efficacy during distribution.[9]
-
Recipharm: Specializes in sterile and solid dosage form manufacturing, supporting large-volume production with quality assurance.[10]
Distribution and Logistics
Distribution channels for Suzetrigine rely on global logistics providers equipped to handle delicate pharmaceuticals.
1. Specialized Logistics Providers
-
DHL Pharmaceutical Logistics: Provides temperature-controlled transportation for Suzetrigine, maintaining stability during transit.[11]
-
UPS Healthcare: Offers end-to-end supply chain management with real-time tracking, ensuring timely delivery in compliance with regulatory standards.[12]
Regulatory and Quality Compliance
Suppliers involved in Suzetrigine’s supply chain must meet international standards such as GMP, ISO certifications, and Good Distribution Practice (GDP). Ensuring supplier compliance minimizes risks associated with counterfeit or substandard products.
Emerging Supply Chain Trends
-
Supply Chain Diversification: To mitigate risks like geopolitical tensions or pandemic disruptions, companies are diversifying suppliers geographically, sourcing from regions such as Southeast Asia, Europe, and North America.
-
Vertical Integration: Some pharmaceutical developers develop its own API production capabilities to secure supply and meet regulatory requirements initially.
-
Digital Supply Chain Management: Real-time tracking and blockchain technology are increasingly employed to enhance transparency and traceability of Suzetrigine’s supply chain.
Key Supplier Selection Criteria
- Compliance with GMP and regulatory standards
- Proven track record in pharmaceutical manufacturing
- Supply chain reliability and capacity
- Quality control measures
- Cost competitiveness
- Geographic diversification to minimize risk
Conclusion
The supply ecosystem for Suzetrigine spans from raw material suppliers, API manufacturers, formulation providers, to logistics companies. Leading industry players such as BASF, Dow, Lonza, WuXi, and Catalent dominate the landscape, driven by their extensive manufacturing expertise and regulatory compliance. Companies seeking to optimize their Suzetrigine supply chain should prioritize supplier diversification, enforce strict quality standards, and leverage innovative supply chain technologies to maintain resilience and regulatory adherence.
Key Takeaways
- Robust sourcing from diversified suppliers minimizes risks associated with geopolitical and logistic disruptions.
- Compliance, especially with GMP and ISO standards, remains the foremost criterion in supplier selection.
- Vertical integration of API production can enhance supply security, particularly during early commercial phases.
- The evolution of digital supply chain solutions enhances traceability and compliance.
- Monitoring emerging regional suppliers can provide cost advantages and supply assurance.
FAQs
Q1: Who are the primary API suppliers for Suzetrigine?
A1: Major API suppliers include Lonza and WuXi AppTec, both of which provide GMP-compliant manufacturing capabilities tailored for Suzetrigine.
Q2: What regions dominate Suzetrigine’s supply chain?
A2: Key regions include Europe (BASF, Lonza), North America (Dow, Catalent), and Asia (WuXi, Jubilant), with diversification strategies increasingly emphasizing Southeast Asia.
Q3: How do regulatory standards impact Suzetrigine suppliers?
A3: Suppliers must adhere to GMP, ISO, and GDP standards, ensuring product quality, safety, and regulatory approval, which are critical for market access.
Q4: Are there opportunities for new entrants in Suzetrigine’s supply chain?
A4: Yes, especially in regional API manufacturing and excipient supply, but entry requires rigorous compliance with pharmaceutical standards.
Q5: How does supply chain resilience influence Suzetrigine market strategy?
A5: Resilient supply chains reduce delays, ensure steady availability, and mitigate risks, directly impacting market competitiveness and reputation.
References
[1] BASF SE. Chemical Supply for Pharmaceutical Manufacturing. 2022.
[2] Dow Chemical. Innovative Raw Materials for Drug Synthesis. 2022.
[3] Teva Pharmaceutical Industries Ltd. API Manufacturing Capabilities. 2021.
[4] Cayman Chemical. High-Purity Chemical Intermediates. 2022.
[5] Lonza Group. API Production for Pharmaceuticals. 2023.
[6] WuXi AppTec. Contract Manufacturing Services. 2023.
[7] Mallinckrodt Pharmaceuticals. Pharmaceutical Excipients. 2022.
[8] Jubilant Lifesciences. Formulation Excipients Portfolio. 2022.
[9] Catalent Inc. Advanced Pharmaceutical Manufacturing. 2023.
[10] Recipharm. Scale-up Production & Packaging. 2022.
[11] DHL Pharma Logistics. Temperature-Controlled Transportation. 2023.
[12] UPS Healthcare. Global Pharmaceutical Logistics. 2023.
This comprehensive overview enables stakeholders to make informed strategic decisions regarding Suzetrigine’s supply chain, emphasizing quality, compliance, and resilience.
More… ↓
